Difference between revisions of "Team:ETH Zurich/Achievements"
Line 37: | Line 37: | ||
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Genetic_circuit">genetic circuit</a> that integrates two different cancer specific signals (<a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">lactate </a>and <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module">AHL</a>)in an <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Combined_Model#Combined_Model">AND gate</a>.</li> | <li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Genetic_circuit">genetic circuit</a> that integrates two different cancer specific signals (<a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">lactate </a>and <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module">AHL</a>)in an <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Combined_Model#Combined_Model">AND gate</a>.</li> | ||
− | <li>We implemented a method to do single cell analysis of cancer cells by <a href="https://2015.igem.org/Team:ETH_Zurich/Design#System_Overview" | + | <li>We implemented a method to do single cell analysis of cancer cells by <a href="https://2015.igem.org/Team:ETH_Zurich/Design#System_Overview">expressing Annexin V in the <i> E. coli</i> outer membrane</a>, which enables them to selectively bind to apoptotic cancer cells.</li> |
− | <li> | + | <li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We designed 8 synthetic <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">LldR dependent promoters</a> and characterized them. Additionally, the influence of the lacate importer LldP was characterized.</li> |
− | <li> | + | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a very limited amount of information present in the literature.</li> |
− | <li>We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li> | + | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li> |
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for later easy application of our MicroBeacon <i>E. coli</i>.</li> | <li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for later easy application of our MicroBeacon <i>E. coli</i>.</li> | ||
Line 59: | Line 59: | ||
<h3>Human Practices Achievements</h3> | <h3>Human Practices Achievements</h3> | ||
+ | <ul> | ||
− | + | <li><img src="https://static.igem.org/mediawiki/2015/e/e8/ETH15_Silver_medal.png" align="right" width="1.8%">We went to two different schools, thaught the children about what DNA is, performed experiments with them and published an <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Awareness#_Newspaper_Articles_">article about it in the local newspaper</a>.</li> | |
− | <li> | + | <li><img src="https://static.igem.org/mediawiki/2015/e/e8/ETH15_Silver_medal.png" align="right" width="1.8%">We told the ETH-student magacine <a href="http://www.vseth.ethz.ch/polykum/archiv#2014/2015">polykum</a> about iGEM and gave an interview.</li> |
− | <li> | + | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Stockholm">collaborated</a> with the team from <a href="https://2015.igem.org/Team:Stockholm"> Stockholm</a> by testing some of their constructs.</li> |
− | <li>We | + | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Amoy">contributed</a> to the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">Newsletters</a> from <a href="https://2015.igem.org/Team:Amoy#">Amoys team</a>, met with the <a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt team</a>, helped with a survey from <a href="https://2015.igem.org/Team:EPF_Lausanne">EPFL</a> and provided <a href="https://2015.igem.org/Team:Uniandes_Colombia">Colombias team</a> with protocols and <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Colombia">advice</a> when their transformations did not work.</li> |
− | + | ||
− | < | + | |
+ | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We <a href="https://2015.igem.org/Team:ETH_Zurich/Practices">interviewed many different experts</a> from various fields, such as <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Medicine">medical doctors</a>, <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Ethics">somebody from the ethics commission</a>, the <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Business">founder of a start-up</a> or an <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Patents">expert in patents law</a> and <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Influence_of_human_practices">integrated the advice and ideas</a> we got from them into the <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Design">design</a>.</li> | ||
+ | </ul> | ||
<p></p> | <p></p> | ||
<p></p> | <p></p> |
Revision as of 08:31, 18 September 2015
- Project
- Modeling
- Lab
- Human
Practices - Parts
- About Us
Achievements
We are proud to announce that we achieved the following goals
General Achievements
- We completed the Judging Form
- We created a description of our project in time and documented each aspect of the project on this page.
- Documented 20 parts taken from the Registry of Standard Biological Parts.
Experimental Achievements
- We designed a novel system for detection of circulating tumour cells in blood samples using genetically modified bacteria.
- We designed a genetic circuit that integrates two different cancer specific signals (lactate and AHL)in an AND gate.
- We implemented a method to do single cell analysis of cancer cells by expressing Annexin V in the E. coli outer membrane, which enables them to selectively bind to apoptotic cancer cells.
- We designed 8 synthetic LldR dependent promoters and characterized them. Additionally, the influence of the lacate importer LldP was characterized.
- We characterized parts of the natural E. coli lldPRD-operon, on which there is only a very limited amount of information present in the literature.
- We documented and submitted two new basic parts to the iGEM parts registry and created a part collection with 14 parts.
- We designed a chip for later easy application of our MicroBeacon E. coli.
- We participated in the interlab study.
- Our experiments complied with the safety instructions at the Department of Biosystems Science and Engineering D-BSSE in Basel where our lab is situated.
Modeling Achievements
- By modeling the system we showed that the system as a whole can work.
Human Practices Achievements
- We went to two different schools, thaught the children about what DNA is, performed experiments with them and published an article about it in the local newspaper.
- We told the ETH-student magacine polykum about iGEM and gave an interview.
- We collaborated with the team from Stockholm by testing some of their constructs.
- We contributed to the Newsletters from Amoys team, met with the Darmstadt team, helped with a survey from EPFL and provided Colombias team with protocols and advice when their transformations did not work.
- We interviewed many different experts from various fields, such as medical doctors, somebody from the ethics commission, the founder of a start-up or an expert in patents law and integrated the advice and ideas we got from them into the design.